ANTINEOPLASTIC AGENTS
Clinical trials for ANTINEOPLASTIC AGENTS explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTIC AGENTS trials appear
Sign up with your email to follow new studies for ANTINEOPLASTIC AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney cancer: vorolanib tested as Second-Line therapy
Disease control Recruiting nowThis study tests the drug vorolanib in people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after the first one stopped working. The goal is to see how long the drug controls the cancer and what side ef…
Matched conditions: ANTINEOPLASTIC AGENTS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 05:22 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Poop pills may soothe chemo belly blues for cancer patients
Symptom relief Recruiting nowThis study looks at whether fecal microbiota transplantation (FMT) can reduce or prevent stomach and bowel side effects from chemotherapy in people with advanced gastrointestinal cancers. About 90 adults with stage IV cancer will receive FMT during their 4th chemo cycle. The goal…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 05:21 UTC